<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00892814</url>
  </required_header>
  <id_info>
    <org_study_id>DBCG PBI protocol</org_study_id>
    <secondary_id>CIRRO IP030109</secondary_id>
    <nct_id>NCT00892814</nct_id>
  </id_info>
  <brief_title>Partial Breast Versus Whole Breast Irradiation in Elderly Women Operated on for Early Breast Cancer</brief_title>
  <official_title>Partial Breast Versus Whole Breast Irradiation to Women ≥ 60 Years Operated With Breast Conservation for Early Breast Cancer: a Randomized Fase II Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Danish Breast Cancer Cooperative Group</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Danish Center for Interventional Research in Radiation Oncology (CIRRO)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Danish Cancer Society</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Danish Breast Cancer Cooperative Group</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this trial is to investigate the difference in late radiation morbidity
      between partial breast irradiation and whole breast irradiation given to women operated on
      with breast conservation surgery for early breast cancer with a low risk of local recurrence.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is 2-armed. In both treatment arms the radiotherapy consists of 40 Gy in 15
      fractions, 2.67 Gy per fraction. The primary endpoint in the trial is late radiation
      morbidity evaluated as fibrosis, secondary endpoints are other types of late morbidity, rate
      of local recurrence and an attempt to establish a genetic risk profile for development of
      late radiation morbidity.

      The hypothesis is that women operated with breast conservation for a breast carcinoma with
      low risk of local recurrence can be offered partial breast irradiation without risking more
      late radiation morbidity compared to whole breast irradiation.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>May 2009</start_date>
  <completion_date type="Anticipated">March 2026</completion_date>
  <primary_completion_date type="Actual">March 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Grade 2 and/or 3 fibrosis after radiotherapy</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Any other late morbidity after adjuvant radiotherapy, genetic risk profile for late morbidity, recurrence/survival</measure>
    <time_frame>10 years</time_frame>
    <description>morbidity and recurrences</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">882</enrollment>
  <condition>Breast Carcinoma</condition>
  <arm_group>
    <arm_group_label>Partial breast irradiation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>40 Gy/15 fractions, 3 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Whole breast irradiation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>40 Gy/15 fractions, 3 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Partial breast irradiation</intervention_name>
    <description>40 Gy/15 fractions, 3 weeks</description>
    <arm_group_label>Partial breast irradiation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Whole breast irradiation</intervention_name>
    <description>40 Gy/15 fractions, 3 weeks</description>
    <arm_group_label>Whole breast irradiation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  women 60 years or older

          -  operated for unilateral, unifocal early breast cancer pT1, pN0, M0, grade I or II,
             positive estrogen and/or progesterone receptor, HER2 negative

        Exclusion Criteria:

          -  lobular carcinoma
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lars Stenbygaard, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Aalborg Universitetshospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Erik Jacobsen, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Vejle Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mette H Nielsen, MD, phd</last_name>
    <role>Study Chair</role>
    <affiliation>Odense University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anders N Pedersen, MD, phd</last_name>
    <role>Study Chair</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Birgitte Offersen, MD, phd</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aarhus University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Danish Breast Cancer Cooperative Group</name>
      <address>
        <city>Copenhagen</city>
        <state>Copenhagen Ø</state>
        <zip>DK-2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <reference>
    <citation>Offersen BV, Overgaard M, Kroman N, Overgaard J. Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: a systematic review. Radiother Oncol. 2009 Jan;90(1):1-13. doi: 10.1016/j.radonc.2008.08.005. Epub 2008 Sep 8. Review. Erratum in: Radiother Oncol. 2011 May;99(2):254. Radiother Oncol. 2011 Feb;98(2):254.</citation>
    <PMID>18783840</PMID>
  </reference>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 4, 2009</study_first_submitted>
  <study_first_submitted_qc>May 4, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 5, 2009</study_first_posted>
  <last_update_submitted>July 31, 2017</last_update_submitted>
  <last_update_submitted_qc>July 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Danish Breast Cancer Cooperative Group</investigator_affiliation>
    <investigator_full_name>Birgitte Offersen</investigator_full_name>
    <investigator_title>M.D., Ph.D., ass. professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

